SIRT3 is a novel metabolic driver of and therapeutic target for chemotherapy resistant DLBCLs Meeting Abstract
| Authors: | Li, M.; Chiang, Y. L.; Lyssiotis, C.; Teater, M.; Shen, H.; Wang, L.; Hong, J. Y.; Jin, H.; Duy, C.; Mistry, S.; Cerchietti, L.; Cross, J.; Cantley, L.; Lin, H.; Melnick, A. |
| Abstract Title: | SIRT3 is a novel metabolic driver of and therapeutic target for chemotherapy resistant DLBCLs |
| Meeting Title: | 59th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 130 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2017 Dec 9-12 |
| Meeting Location: | Atlanta, GA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2017-12-07 |
| Language: | English |
| ACCESSION: | WOS:000432419401290 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V130.Suppl_1.643.643 |
| Notes: | Meeting Abstract: 643 -- Source: Wos |
